Subsequently, the same group showed that plasma DJ-1 or α-synuclein levels did not differ in PD cases compared to age-matched controls and AD cases, and concluded that, unlike in the CSF, total DJ-1 or α-synuclein in plasma alone is not useful as a biomarker for diagnosis, progression or severity of PD [12]. The gene discussed is SNCA; the disease is Alzheimer disease.